Inflammatory profiles in nasal mucosa of patients with persistent vs intermittent allergic rhinitis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 65, Issue 9, 2010, Pages 1149-1157

  Liu, F ^a   Zhang, J ^a   Liu, Y ^a   Zhang, N ^b   Holtappels, G ^b   Lin, P ^a   Liu, S ^a   Bachert, C ^b  

^a SICHUAN UNIVERSITY   (China)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

eosinophilic inflammation; forkhead box P3; GATA 3; interleukin 5; intermittent allergic rhinitis (IAR); persistent allergic rhinitis (PER)

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN E; INTERLEUKIN 5; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; MESSENGER RNA; PROSTAGLANDIN D2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR RORC; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EOSINOPHIL; FEMALE; HAY FEVER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MALE; MAST CELL; MEDIATOR RELEASE; NOSE MUCOSA; PERENNIAL RHINITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TURBINATE; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; EOSINOPHILIA; EOSINOPHILS; FEMALE; GATA3 TRANSCRIPTION FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-5; MALE; MAST CELLS; NASAL MUCOSA; RHINITIS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; TH2 CELLS; YOUNG ADULT;

EID: 77955337775     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2010.02340.x     Document Type: Article

References (36)

1. Bachert C, van Cauwenberge P, Olbrecht J, van Schoor J. Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium. Allergy 2006 61 : 693 698.
2. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 2004 24 : 758 764.
3. Bousquet J, Van CP, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001 108 (5 Suppl S147 S334.
4. Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Tilles SA et al. The diagnosis and management of rhinitis: an updated practice parameter. Joint Task Force on Practice Parameters. J Allergy Clin Immunol 2008 122 : S1 S84.
5. Zhang L, Han D, Huang D, Wu Y, Dong Z, Xu G et al. Prevalence of self-reported allergic rhinitis in eleven major cities in china. Int Arch Allergy Immunol 2009 149 : 47 57.
6. Kong WJ, Chen JJ, Zheng ZY, Shi QM, Zhou Y. Prevalence of allergic rhinitis in 3-6-year-old children in Wuhan of China. Clin Exp Allergy 2009 39 : 869 874.
7. Schoenwetter WF, Dupclay L, Appajosyula S, Botteman MF, Pashos CL. Economic impact and quality of life burden of allergic rhinitis. Curr Med Res Opin 2004 20 : 305 317.
8. Reed SD, Lee TA, McCrory DC. The economic burden of allergic rhinitis. Pharmacoeconomics 2004 22 : 345 361.
9. Jeffery PK, Haahtela T. Allergic rhinitis and asthma: inflammation in a one-airway condition. BMC Pulm Med 2006 6 (Suppl 1 S5.
10. Gelfand EW. Inflammatory mediators in allergic rhinitis. J Allergy Clin Immunol 2004 114 (5 Suppl S135 S138.
11. Yuksel H, Yilmaz O, Sogut A, Ertan P, Onur E. Correlation of quality of life with clinical parameters and eosinophilic cationic protein levels in children with allergic rhinoconjunctivitis. Int Arch Allergy Immunol 2009 148 : 18 22.
12. Winther L, Moseholm L, Reimert CM, Stahl Skov P, Kaergaard Poulsen L. Basophil histamine release, IgE, eosinophil counts, ECP, and EPX are related to the severity of symptoms in seasonal allergic rhinitis. Allergy 1999 54 : 436 445.
13. Chen ST, Sun HL, Lu KH, Lue KH, Chou MC. Correlation of immunoglobulin E, eosinophil cationic protein, and eosinophil count with the severity of childhood perennial allergic rhinitis. J Microbiol Immunol Infect 2006 39 : 212 218.
14. Klaewsongkram J, Ruxrungtham K, Wannakrairot P, Ruangvejvorachai P, Phanupak P. Eosinophil count in nasal mucosa is more suitable than the number of ICAM-1-positive nasal epithelial cells to evaluate the severity of house dust mite-sensitive allergic rhinitis: a clinical correlation study. Int Arch Allergy Immunol 2003 132 : 68 75.
15. Chaplin DD 1. Overview of the human immune response. J Allergy Clin Immunol 2006 117 (2 Suppl Mini-Primer S430 S435.
16. Koscher V, Milhe F, El Biaze M, Vervloet D, Magnan A. Variation of T-cell activation in allergic subjects during natural pollen exposure. Allergy 2006 61 : 35 42.
17. Zhang N, Van Zele T, Perez-Novo C, Van Bruaene N, Holtappels G, DeRuyck N et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol 2008 122 : 961 968.
18. Zhang N, Holtappels G, Claeys C, Huang G, van Cauwenberge P, Bachert C. Pattern of inflammation and impact of Staphylococcus aureus enterotoxins in nasal polyps from southern China. Am J Rhinol 2006 20 : 445 450.
19. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008 63 (Suppl 86 8 160.
20. Perez-Novo CA, Claeys C, Speleman F, Van Cauwenberge P, Bachert C, Vandesompele J. Impact of RNA quality on reference gene expression stability. BioTechniques 2005 54 : 56.
21. Broide D. New perspectives on mechanisms underlying chronic allergic inflammation and asthma in 2007. J Allergy Clin Immunol 2008 122 : 475 480.
22. Boyce JA, Broide D, Matsumoto K, Bochner BS. Advances in mechanisms of asthma, allergy, and immunology in 2008. J Allergy Clin Immunol 2009 123 : 569 574.
23. Prussin C, Metcalfe DD IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 2006 117 (2 Suppl Mini-Primer S450 S456.
24. Peters-Golden M, Gleason MM, Togias A. Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis. Clin Exp Allergy 2006 36 : 689 703.
25. Ciprandi G, Marseglia GL, Klersy C, Tosca MA. Relationships between allergic inflammation and nasal airflow in children with persistent allergic rhinitis due to mite sensitization. Allergy 2005 60 : 957 960. (Pubitemid 40813820)
26. Barnes PJ. Role of GATA-3 in allergic diseases. Curr Mol Med 2008 8 : 330 334.
27. Nasta F, Ubaldi V, Pace L, Doria G, Pioli C. Cytotoxic T-lymphocyte antigen-4 inhibits GATA-3 but not T-bet mRNA expression during T helper cell differentiation. Immunology 2006 117 : 358 367.
28. Maneechotesuwan K, Xin Y, Ito K, Jazrawi E, Lee KY, Usmani OS et al. Regulation of Th2 cytokine genes by p38 MAPK-mediated phosphorylation of GATA-3. J Immunol 2007 178 : 2491 2498.
29. Nakamura Y, Christodoulopoulos P, Cameron L, Wright E, Lavigne F, Toda M et al. Upregulation of the transcription factor GATA-3 in upper airway mucosa after in vivo and in vitro allergen challenge. J Allergy Clin Immunol 2000 105 : 1146 1152.
30. Malmhäll C, Bossios A, Pullerits T, Lötvall J. Effects of pollen and nasal glucocorticoid on FOXP3+, GATA-3+ and T-bet+ cells in allergic rhinitis. Allergy 2007 62 : 1007 1013.
31. Usui T, Preiss JC, Kanno Y, Yao ZJ, Bream JH, O'Shea JJ et al. T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFNG gene acetylation and transcription. J Exp Med 2006 203 : 755 766.
32. Paik Y, Dahl M, Fang D, Calhoun K. Update: the role of FoxP3 in allergic disease. Curr Opin Otolaryngol Head Neck Surg 2008 16 : 275 279.
33. Lee SM, Gao B, Dahl M, Calhoun K, Fang D. Decreased FoxP3 gene expression in the nasal secretions from patients with allergic rhinitis. Otolaryngol Head Neck Surg 2009 140 : 197 201.
34. Radulovic S, Jacobson MR, Durham SR, Nouri-Aria KT. Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25 + cells in the nasal mucosa. J Allergy Clin Immunol 2008 121 : 1467 1472.
35. O'Hehir RE, Gardner LM, de Leon MP, Hales BJ, Biondo M, Douglass JA et al. House dust mite sublingual immunotherapy - the role for TGF-beta and functional regulatory T cells. Am J Respir Crit Care Med 2009 180 : 936 947.
36. Oboki K, Ohno T, Saito H, Nakae S. Th17 and allergy. Allergol Int 2008 57 : 121 134.